EUVIMEDEUVIMED entdecken
Fallbericht

Two Japanese Cases Highlighting Structural and Phenotypic Overlap in AGO1 ‐ and AGO2 ‐Related Neurodevelopmental Disorders

Munetsugu Hara iD, Nobuhiko Okamoto iD, Yukihiro Kitai iD, Yoriko Watanabe iD, Naoko Matsumoto, Kaori Fukui iD, Ryuta Takase iD, Yukina Hayashi, Atsushi Fujita, Kumiko Yanagi iD, Tadashi Kaname iD, Naomichi Matsumoto iD

Clinical Genetics · 2026

DOI: 10.1111/cge.70229 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Genetics, 2026. Verfasst von Munetsugu Hara und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pediatrics and Child Health, Kurume University School of Medicine, Fukuoka, Japan. Hauptthemen laut MEDLINE: Argonaute Proteins, Neurodevelopmental Disorders, Eukaryotic Initiation Factors. Die Arbeit nennt 14 Literaturangaben. Gefördert von: National Center of Neurology and Psychiatry (NCNP), Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic variants in AGO1 and AGO2, core components of the Argonaute family, have emerged as causes of rare neurodevelopmental disorders characterized by intellectual disability, marked language impairment, behavioral abnormalities, and distinctive craniofacial features. Reported variants cluster at the L1–PAZ boundary, a structurally sensitive region essential for guide‐RNA engagement. We describe two unrelated Japanese individuals carrying de novo variants in AGO1 (NM_012199.5):c.569T>C p.(Leu190Pro) or AGO2 (NM_012154.6):c.544_546del p.(Phe182del), affecting structurally corresponding residues within this boundary. Both individuals exhibited global developmental delay, hypotonia, midface hypoplasia, thin upper lip, elongated facial shape, and reduced cerebral white matter volume, aligning with previously reported AGO1‐ and AGO2‐related phenotypes. Structural assessment using AlphaFold2‐based AGO1 models and the AGO2 crystal structure confirmed positional equivalence of the affected residues, supporting the concept of a shared structural vulnerability across Argonaute paralogs. These observations expand the phenotypic spectrum of Argonaute‐related neurodevelopmental disorders in the Japanese population and highlight RNA‐regulatory dysfunction as a coherent pathogenic axis. Recognition of this clinical gestalt may assist clinicians in prioritizing AGO1 and AGO2 during genomic evaluation of unexplained neurodevelopmental disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Argonaute ProteinsNeurodevelopmental DisordersEukaryotic Initiation FactorsHumansPhenotypeMaleFemaleMutationChildChild, PreschoolJapanEast Asian People

Stichwörter der Autor:innen

AGO1AGO2ArgonauteL1–PAZ boundaryRNA regulationneurodevelopmental disorder

Substanzen

Argonaute ProteinsAGO1 protein, humanAGO2 protein, humanEukaryotic Initiation Factors

Autor:innen und Institutionen

  • Departments of Pediatrics and Child Health, Kurume University School of Medicine, Fukuoka, Japan.
  • Department of Medical Genetics, Osaka Women's and Children's Hospital, Osaka, Japan.
  • Department of Pediatric Neurology, Bobath Memorial Hospital, Osaka, Japan.
  • Department of Pediatrics, Yamaguchi Redcross Hospital, Yamaguchi, Japan.
  • Department of Human Genetics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
  • Department of Genome Medicine, National Center for Child Health and Development, Tokyo, Japan.

ORCID-Profile: Munetsugu Hara, Nobuhiko Okamoto, Yukihiro Kitai, Yoriko Watanabe, Kaori Fukui, Ryuta Takase, Kumiko Yanagi, Tadashi Kaname, Naomichi Matsumoto

Förderung

  • National Center of Neurology and Psychiatry (NCNP)
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Takeda Science Foundation
  • Ministry of Health, Labour and Welfare

Zitieren

APA

Hara, M., Okamoto, N., Kitai, Y., Watanabe, Y., Matsumoto, N., Fukui, K., Takase, R., Hayashi, Y., Fujita, A., Yanagi, K., Kaname, T., & Matsumoto, N. (2026). Two Japanese Cases Highlighting Structural and Phenotypic Overlap in AGO1 ‐ and AGO2 ‐Related Neurodevelopmental Disorders. Clinical Genetics. https://doi.org/10.1111/cge.70229

Vancouver

Hara M, Okamoto N, Kitai Y, Watanabe Y, Matsumoto N, Fukui K, et al. Two Japanese Cases Highlighting Structural and Phenotypic Overlap in AGO1 ‐ and AGO2 ‐Related Neurodevelopmental Disorders. Clinical Genetics. 2026. doi:10.1111/cge.70229

BibTeX
@article{Hara2026,
  author = {Hara, Munetsugu and Okamoto, Nobuhiko and Kitai, Yukihiro and Watanabe, Yoriko and Matsumoto, Naoko and Fukui, Kaori and Takase, Ryuta and Hayashi, Yukina and Fujita, Atsushi and Yanagi, Kumiko and Kaname, Tadashi and Matsumoto, Naomichi},
  title = {Two Japanese Cases Highlighting Structural and Phenotypic Overlap in AGO1 ‐ and AGO2 ‐Related Neurodevelopmental Disorders},
  journal = {Clinical Genetics},
  year = {2026},
  doi = {10.1111/cge.70229}
}
Kostenlos starten →